Acute Thrombocytopenia after Initiating Anticoagulation with Rivaroxaban
نویسندگان
چکیده
منابع مشابه
Acute thrombocytopenia after initiating anticoagulation with rivaroxaban.
A 75-year-old man with paroxysmal atrial fibrillation developed a traumatic intracranial hemorrhage during warfarin treatment. The administration of warfarin was stopped and rivaroxaban therapy, a novel oral anticoagulant (NOAC), was started. Immediately, his platelet count decreased to 3.7×10(4) /μL. The platelet count recovered rapidly after cessation of rivaroxaban administration. Developmen...
متن کاملAcute severe thrombocytopenia after treatment with ReoPro (abciximab).
ReoPro (abciximab) is an extremely potent inhibitor of the glycoprotein IIb/IIIa receptor, the final common pathway of platelet activation and aggregation. Its main role is the maintenance of coronary patency after suboptimal results with coronary intervention. However, one of the complications of this treatment is excessive bleeding, a problem which may be compounded by a rare idiosyncratic th...
متن کاملArgatroban anticoagulation in patients with heparin-induced thrombocytopenia.
BACKGROUND Heparin-induced thrombocytopenia (HIT) is an intensely prothrombotic syndrome managed by discontinuation of heparin therapy and substitution of an alternative inhibitor of thrombin. We describe our experience with argatroban, a direct thrombin inhibitor, in patients with HIT or HIT with thrombosis (HITTS). METHODS In this multicenter, nonrandomized prospective study, 418 patients w...
متن کاملSafety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia.
OBJECTIVES Venous limb gangrene has been reported to occur after high warfarin doses in heparin-induced thrombocytopenia (HIT), and this observation has been used to exclude warfarin management in this condition. The outcome of patients receiving modest doses of warfarin was studied. DESIGN Retrospective study of 114 consecutive HIT patients who received diagnoses by platelet aggregometry; 51...
متن کاملAssociation of rivaroxaban anticoagulation and spontaneous vitreous hemorrhage.
IMPORTANCE Rivaroxaban is an anticoagulant prescribed for the management of atrial fibrillation. We describe a correlation between rivaroxaban and spontaneous vitreous hemorrhage. OBSERVATIONS Three patients developed spontaneous vitreous hemorrhage after initiating rivaroxaban anticoagulation. All 3 patients were taking an additional anticoagulant at the time of hemorrhage. CONCLUSIONS AND...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Internal Medicine
سال: 2014
ISSN: 0918-2918,1349-7235
DOI: 10.2169/internalmedicine.53.2890